Home › Chronic Progressive Multiple Sclerosis › Kansas
Chronic Progressive Multiple Sclerosis clinical trials in Kansas
4 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Kansas.
Cities in Kansas
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- KC Research Center, PA Neurology Research Dept, Roeland Park
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 30, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- University of Kansas Medical Center, Kansas City
- KC Research Center, PA Neurology Research Department, Roeland Park
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 22, 2026 · NCT07067463Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- University of Kansas Hospital, Kansas City
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.